Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?
Eur J Hosp Pharm
; 26(4): 243-244, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-31338185
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Eur J Hosp Pharm
Year:
2019
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom